Fibroblast growth factor-23 (FGF-23) and Klotho have been proven to contribute to chronic kidney disease-mineral and bone disorder (CKD-MBD) in patients undergoing hemodialysis. Previous evidence ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

If you’re looking for an extra tightening boost for your skin care routine (without turning to neurotoxins like Botox), it might be a good idea to try using a growth factor serum. Below ...

Goldman Sachs & Co. LLC, Leerink Partners and BofA Securities are acting as lead book-running managers and Cantor is acting ...

Growth factor signalling is a cell signalling pathway that regulates the growth and development of an organism. Secreted growth factors bind to transmembrane growth factor receptors to stimulate ...

He hunts for downtrodden cyclical firms whose market expectations are undeservedly gloomy and secular-growth companies whose magnitude or duration of growth is underappreciated. That framework is ...

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

Syn-Coll, a synthetic tripeptide derived from the collagen sequence, has garnered attention in scientific research for its hypothesized potential to influence processes associated with extracellular ...

Additionally, it confirmed existing values for matter density, the Hubble constant, and structure growth. In the dynamical dark energy analysis, the team found no strong evidence for dynamical ...

An alternative signaling pathway, controlled by FGFR1 (fibroblast growth factor receptor 1), steps in and ensures growth and survival. "With the help of such 'bypasses', tumors react to external ...

Analysts at Proshare have raised concerns about the shallow structure and limited breadth of Nigeria’s capital market, warning that these factors continue to hinder its growth and potential to ...

New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...